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Abstract
Tumor stroma has an active role in the initiation, growth, and propagation of many tumor types by secreting growth factors
and modulating redox status of the microenvironment. Although PPARβ/δ in ﬁbroblasts was shown to modulate oxidative
stress in the wound microenvironment, there has been no evidence of a similar effect in the tumor stroma. Here, we present
evidence of oxidative stress modulation by intestinal stromal PPARβ/δ, using a FSPCre-Pparb/d−/− mouse model and
validated it with immortalized cell lines. The FSPCre-Pparb/d−/− mice developed fewer intestinal polyps and survived
longer when compared with Pparb/dﬂ/ﬂ mice. The pre-treatment of FSPCre-Pparb/d−/− and Pparb/dﬂ/ﬂ with antioxidant N-
acetyl-cysteine prior DSS-induced tumorigenesis resulted in lower tumor load. Gene expression analyses implicated an
altered oxidative stress processes. Indeed, the FSPCre-Pparb/d−/− intestinal tumors have reduced oxidative stress than
Pparb/dﬂ/ﬂ tumors. Similarly, the colorectal cancer cells and human colon epithelial cells also experienced lower oxidative
stress when co-cultured with ﬁbroblasts depleted of PPARβ/δ expression. Therefore, our results establish a role for ﬁbroblast
PPARβ/δ in epithelial–mesenchymal communication for ROS homeostasis.
Introduction
Tumor initiation, growth, and propagation are frequently
accompanied by desmoplasia and acquisition of a reactive
stroma, mainly comprising leukocytes, ﬁbroblasts, and
endothelial cells [1]. The dynamic and reciprocal relation-
ship between epithelial and mesenchymal compartments of
the tumor dictates almost every aspect of cancer progres-
sion, even governing the efﬁcacy of therapy and inﬂuencing
the risk of disease relapse [2]. This epithelial–mesenchymal
communication has been usually ascribed to a complex
signaling network of growth factors and cytokines. Reactive
oxygen species (ROS) have also been identiﬁed as potent
modiﬁers of signaling pathways and consequently cell
behavior. The balance between production of ROS and their
elimination by antioxidants is important for tissue home-
ostasis [3, 4]. Microenvironmental oxidative stress conjures
protective antioxidant response from tissues to regain
homeostasis. However, ROS imbalance or the loss of
homeostatic control in a continued oxidative micro-
environment can either result in cell death caused by oxi-
dative catastrophe or contribute to carcinogenesis, which are
tissue- and context-dependent [5–7]. Indeed, ROS are by-
products of aberrant cancer cell metabolism and
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mitochondrial defects. However, little is known about the
effect of tumor modulating ROS signals by ﬁbroblasts, the
most prominent cell type in tumor microenvironment.
Recent study showed that a deﬁciency in ﬁbroblast per-
oxisome proliferator-activated receptor β/δ (PPARβ/δ)
increased oxidative stress in wound microenvironment to
delay keratinocyte migration [8]. PPARβ/δ has also been
implicated in the pathogenesis of colorectal cancer (CRC).
However, its role remains controversial as both pro- and
anti-tumorigenic roles was reported from studies using
conventional PPARβ/δ-knockout mice [9, 10]. On one
hand, PPARβ/δ has been shown to exert potent pro-
tumorigenic effects. Early study suggested that nonsteroidal
anti-inﬂammatory drugs (NSAIDs) reduced tumorigenesis
through inhibition of PPARβ/δ [11]. PPARβ/δ has been
shown to promote UV-induced skin tumorigenesis by
upregulating Src expression and activity thereby enhancing
the downstream EGFR/Erk1/2 pathway [12]. PPARβ/δ also
enhanced CRC progression by regulating Glut1 and
SLC10A5 expression, promoting cancer cell metabolic
programming [13]. PPARβ/δ also promoted angiogenesis
by stimulating the expression of VEGF in CRC and bladder
cancer [14–16]. In addition, PPARβ/δ promoted a pro-
tumorigenic inﬂammatory environment through the
increased production of COX-2-derived PGE2 [16]. On the
other hand, PPARβ/δ has also been reported to exert potent
anti-inﬂammatory functions through interfering with the
functions of transcription factors such as NFκB, AP1,
STAT3 [17]. In melanoma, PPARβ/δ exhibited inhibitory
effects on tumorigenicity via the modulation of inﬂamma-
tory and apoptotic mechanisms [18]. In apparent dis-
crepancies with earlier studies, several studies showed that
NSAIDs increased PPARβ/δ expression in human CRC cell
lines, suggesting that elevated PPARβ/δ level, rather than
decreased level, contributed to the chemopreventive effects
of NSAIDs. Using a tissue-speciﬁc approach to delineate
the problem, subsequent studies using an intestinal
epithelia-speciﬁc deletion and transgene overexpression of
PPARβ/δ in mice supported a pro-tumorigenic role for
epithelial PPARβ/δ [19, 20]. Recent work on skin squamous
cell carcinoma showed that the expression of PPARβ/δ was
reduced in cancer-associated ﬁbroblasts [21]. Further
investigation revealed that PPARβ/δ in cancer-associated
ﬁbroblasts reduced the invasiveness, xenobiotic resistance
and cellular bioenergetics of the adjacent epithelial cancer,
at least, in part via the secretion of growth factors and
cytokines [21]. However, the role of ﬁbroblast PPARβ/δ in
the initiation and progression of CRC remains unclear.
Our understanding on the role of ﬁbroblasts in pathologic
conditions is hampered by the absence of speciﬁc markers.
Fibroblast-speciﬁc protein (FSP)1 (or S100A-4) has been
suggested as a ﬁbroblast-speciﬁc marker in normal and
ﬁbrotic tissues. The intestinal mesenchyme comprises of a
heterogeneous population of stromal cells of varying origins
[22]. FSP1-directed deletion occurs in ﬁbroblast sub-
population that had an active FSP1 promoter activity.
Although FSP1 has been identiﬁed as a ﬁbroblast marker
and used for ﬁbroblast depletion [23, 24], the complete
coverage of the entire ﬁbroblast population by a single
marker has proven to be tricky. Although FSP1 is only
expressed in the mesenchymal lineage and commonly used
for stromal-speciﬁc gene deletion strategy, it is lowly
expressed if at all, in matured ﬁbroblasts and myoﬁbro-
blasts. Despite these limitations, FSP1 reporter mice and
FSP1-Cre-driven gene deletion are considered reliable
strategies to investigate ﬁbroblast biology. Transgenic mice
with green ﬂuorescent protein expression driven by the
FSP1 promoter have been used to map cell fate in ﬁbroblast
populations, and that FSP1-Cre animals have served as
important tools to dissect the effects of ﬁbroblast-speciﬁc
gene deletion in ﬁbrotic and neoplastic conditions. FSP1-
directed deletion of genes, like Smoothened, PTEN, TGF
receptor type II, and BMP receptor 2 in the ﬁbroblasts have
been used to study their roles in different tumor types such
as acinar–ductal metaplasia, prostate, breast, and squamous
cell carcinoma of the forestomach [25–28].
Drawing on the parallels between wound healing and
cancer, we investigated the role of ﬁbroblast PPARβ/δ in
CRC. We generated a mouse whose PPARβ/δ gene was
deleted in the ﬁbroblasts (FSPCre-Pparb/d−/−) by crossing
a ﬂoxed PPARβ/δ mouse (Pparb/d ﬂ/ﬂ) [29] with transgenic
mice with a Cre transgene under the control of FSP1 pro-
moter (FSP1-Cre) [30]. The FSPCre-Pparb/d−/− mice
developed fewer CRC when compared to their Pparb/dﬂ/ﬂ
littermates, regardless of genetic-, or chemical-induced
carcinogenesis. Microarray gene expression analyses
revealed an altered oxidative processes in adjacent intestinal
or tumor epithelium of FSPCre-Pparb/d−/− mice. We
recapitulated the reduced oxidative stress phenotype in two
human intestinal cancer cell lines (HCT116 and HT29)
when co-cultured with colonic ﬁbroblasts from FSPCre-
Pparb/d−/− mice or ﬁbroblasts whose endogenous PPARβ/δ
were suppressed by siRNA. Taken together, our results
indicate that PPARβ/δ expression in ﬁbroblast modulates
oxidative responses in the adjacent epithelium, and oxida-
tive stress may be an initiating factor in CRC.
Results and discussion
PPARβ/δ expression is ablated in colonic ﬁbroblasts
of FSPCre-Pparb/d−/− mice
We generated a transgenic mouse line harboring a
ﬁbroblast-speciﬁc deletion of PPARβ/δ exon 4 allele
(FSPCre-Pparb/d−/−) (Sng et al., in revision). To study
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ﬁbroblast PPARβ/δ ablation in the gastrointestinal tract, we
examined the deletion PPARβ/δ exon 4 in the different
colonic tissue layers of the FSPCre-Pparb/d−/− transgenic
mice by dissecting the mucosa villi, stroma laminal propria
and muscularis layers with a laser dissecting microscope
(Fig. 1a; Supplementary Fig. 1A–D). Subsequent PCR and
DNA gel analysis conﬁrmed the deletion of exon 4 of
PPARβ/δ gene has occurred in the intestinal ﬁbroblasts,
which were enriched in the locality of the stroma lamina
propria region (Fig. 1b). To examine PPARβ/δ protein
expression in colonic stroma, we enriched for colonic
ﬁbroblasts from FSPCre-Pparb/d−/− and their Pparb/dﬂ/ﬂ
littermates by the ﬁbroblast explant method. Our analysis of
explanted FSPCre-Pparb/d−/− ﬁbroblasts showed a 60 and
80% decrease in PPARβ/δ protein and mRNA levels,
respectively, when compared with Pparb/dﬂ/ﬂ littermates
(Fig. 1c, d). The observed residual PPARβ/δ expression
may be contributed by two technical difﬁculties. As men-
tioned above, FSP1 promoter is active in a subpopulation of
ﬁbroblasts. Although, the explant method is a reliable
method to enrich and culture primary ﬁbroblasts in vitro, it
is also inevitable that other cell types such as endothelial
cells and inﬂammatory immune cells from the stroma might
have contaminated the culture [22, 31]. Importantly, our
observation mirrored that in other studies where FSP1
promoter-driven gene deletion was targeted to the stroma of
breast and pancreatic tissues [26, 30]. Taken together, we
have established that the FSPCre-Pparb/d−/− colonic
mesenchyme harbors perturbed PPARβ/δ expression.
Loss in ﬁbroblast PPARβ/δ expression delays
intestinal tumorigenesis
To investigate the effects of ﬁbroblast PPARβ/δ expression
on intestinal tumorigenesis, we employed three commonly
used murine models, chemical (azoxymethane, AOM, and
dextran sulfate sodium, DSS), genetic (APCmin/+), and
combined (APCmin/+ with DSS) approaches to induce colon
tumors in FSPCre-Pparb/d−/− mice.
Ulcerative colitis and inﬂammatory bowel syndrome are
common risk factors associated with CRC development [32,
33]. Well-established animal models for ulcerative colitis
and inﬂammatory bowel syndrome have used DSS to
induce colitis in mice, thus DSS was used to induce
intestinal inﬂammation in two of the murine models. We
investigated whether there were differences in the inﬂam-
matory processes that lead to tumor initiation. In DSS-
induced colitis, the FSPCre-Pparb/d−/− mice yielded a
lower disease activity index (DAI) (Fig. 2a and Supple-
mentary Table 2), reduced DSS-induced morphological
aberrations and loss of the mucosa layer (Fig. 2b, c) when
compared with wild-type littermates. No signiﬁcant differ-
ence in colon lengths was observed (Fig. 2d). Consistent
with the lower disease severity, we detected a reduction of
pro-inﬂammatory cytokines and an increase of anti-
inﬂammatory cytokines in FSPCre-Pparb/d −/− when
compared with Pparb/d ﬂ/ﬂ mice as determined by multiplex
immunoassay (Supplementary Table 1). These observations
suggest that a deﬁciency in ﬁbroblast PPARβ/δ confers
some protection against colitis, possibly by modulating an
inﬂammatory response.
Next, we looked at chemical induction of colon tumors
using AOM/DSS treatment. In similar fashion to our colitis
experiment, the FSPCre-Pparb/d−/− mice demonstrated
better survival and DAI over the course of AOM/DSS
treatment, compared to the wild-type (Pparb/dﬂ/ﬂ) mice
(Fig. 2e, f). The FSPCre-Pparb/d−/− mice also produced
50% fewer and smaller tumors when compared with Pparb/
dﬂ/ﬂ littermates (Fig. 2g–j). The results showed that the
FSPCre-Pparb/d−/− genetic background confers a protec-
tion against CRC in mice, suggesting that ﬁbroblast
PPARβ/δ is important in the promotion of tumor
development.
To study intestinal tumor formation in a spontaneous
CRC murine model, we crossed FSPCre-Pparb/d−/− mice
to an APCmin/+ background (Supplementary Figure 1E–M).
APCmin/+ mice were either allowed to spontaneously
develop tumors or stimulated chemically by a 1-week DSS
treatment course. First, we noted a lower DAI in APCmin/+
transgenic mice on the FSPCre-Pparb/d−/− background
(Supplementary Figure 1E & F). In both models, we also
noted that mice deﬁcient in ﬁbroblast PPARβ/δ were more
resistant to the disease burden of tumor development
(Supplementary Figure 1G) as suggested by higher survival
rates (Supplementary Figure 1H & K). The mice deﬁcient in
ﬁbroblast PPARβ/δ also developed fewer and smaller
tumors compared to cognate wild-type Pparb/dﬂ/ﬂ litter-
mates (Supplementary Figure 1G, I–J & L-M). Thus,
regardless of the oncogenic stimuli, either with AOM/DSS,
APCmin or combined, our results indicate that reduced
PPARβ/δ expression in ﬁbroblasts delays CRC
development.
Fibroblast PPARβ/δ alters NRF2-mediated response
in FSPCre-Pparb/d−/− intestinal epithelium
To gain mechanistic insight into how PPARβ/δ expression
in ﬁbroblasts mediates changes in its adjacent epithelial
cells, we performed a comparative gene expression analysis
of epithelial and mucosal layers from normal intestines and
tumors from FSPCre-Pparb/d−/− and APCmin/+FSPCre-
Pparb/d−/−. Ingenuity pathway analyses revealed that genes
involved in oxidative phosphorylation and mitochondrial
dysfunction were enriched in FSPCre-Pparb/d−/− mice
(Fig. 3a–c). Interestingly, our upstream regulator analyses
of normal tumor adjacent and tumor epithelia revealed
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enhanced NRF2-mediated stress responses owing to the
deletion of ﬁbroblast PPARβ/δ (Fig. 3d, e). NRF2 is a
master regulator of antioxidant responses through binding
to the antioxidant response elements in the gene’s promoter
region. It upregulates the expression of numerous anti-
oxidant proteins to protect the cell from oxidative damages
[34]. Available experimental evidence also clearly indicates
that NRF2 is an important player in the maintenance of
mitochondrial homeostasis and structural integrity (Holm-
strom, Kostov et al. 2016). This role becomes particularly
critical under conditions of oxidative, electrophilic, and
inﬂammatory stress which inﬂuences the overall health and
survival of the organism. The loss of NRF2 in mouse has
been associated with increased susceptibility to CRC
development [35], underscoring NRF2 as a potential che-
mopreventive target [36]. PPARs have been implicated as
one of the downstream mediators of NRF2 [37]. For
example, functional PPAR response element has been
identiﬁed in the glutathione S-transferase [38, 39], glu-
tathione peroxidase 1, and catalase genes [8]. PPARβ/δ has
also been shown to exert antioxidant effect on cardiomyo-
cytes by inhibiting PI3K/Akt signaling pathway to suppress
ROS generation induced by AngII, however very little is
known about its role in redox regulation in the gut [40–42].
Therefore, we winnowed our attention on NRF2 and asso-
ciated antioxidant genes in the colon of FSPCre-Pparb/d−/−
mice.
We observed an increase in NRF2 expression, con-
comitant with elevated expression of antioxidant enzymes
in intact FSPCre-Pparb/d−/− colons (Fig. 3f). We also
found higher expression of antioxidant (e.g., glutathione
peroxidase and catalase) genes in the FSPCre-Pparb/d−/−
Fig. 1 PPARβ/δ expression is ablated in colonic ﬁbroblasts of FSPCre-
Pparb/d−/− mice. a Representative H&E-stained images of colons
before and after laser capture microdissection of colonic layers,
mucosal, lamina propria, and muscularis. FSPCre-Pparb/d−/− mice
were generated in-house by crossing Pparb/dﬂ/ﬂ and FspCre mice
progenies, and backcrossed with Pparb/dﬂ/ﬂ for at least six generations.
Scale: 500 µm (b) Schematic diagram depicting the relative position of
PCR genotyping primers for ﬂoxed and deleted Pparb/d exon 4 alleles,
at 400 bp (red), and 490 bp (blue), respectively (top). Sample DNA
were processed as instructed in the KAPA Express Extract kit and 2×
KAPA2G Fast Genotyping Mix. DNA gel image showing genotyping
results indicated tissue layers colonic submucosa and lamina propria
layer (L.p.); mucosal villi (Vil.); smooth muscle (Mus.) layers. c
Representative images showing the outgrowth of ﬁbroblasts from
colonic explants from Pparb/dﬂ/ﬂ and FSPCre-Pparb/d−/− mice. Fresh
colons were dissected longitudinally and washed in ice cold phosphate
buffered solution (PBS) containing 30% antimycotic/antibiotic solu-
tion. Specimens were minced to 1–2 mm2 pieces and incubated in fresh
culture media for 72 h to allow colonic ﬁbroblasts to migrate out of the
explants. Migrated cells were washed and cultured for another 48 h
before protein and RNA analyses. Scale bar: 500 µm. c–d Relative fold
change in expression of PPARβ/δ mRNA c and PPARβ/δ protein d in
migrated colonic ﬁbroblasts. Total RNA was extracted from cells
using TRIzol Reagent with E.Z.N.A Total RNA Kit according to
manufacturer’s protocol. Reverse transcription real-time quantitative
PCR (RT-qPCR) were performed with 18S rRNA as a housekeeping
gene. Samples were homogenized and lysed in mammalian protein
extraction reagent (M-PER) supplemented with complete protease
inhibitor mix. Far-infrared immunoblotting was performed. β-tubulin
that served as housekeeping protein was from the same samples. Data
are represented as mean± S.E.M. from at least four independent
experiments
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compared with Pparb/dﬂ/ﬂ intestines (Fig. 3g). This was
supported by increased NRF2 staining in the intestinal villi,
as well as increased nuclear NRF2 protein in FSPCre-
Pparb/d−/− colons (Fig. 3h–i). Indeed, Therefore, our data
provides evidence that NRF2 and its downstream oxidative
stress signaling pathways were elevated in FSPCre-Pparb/d
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−/− colons and may be a major contributing factor for the
reduced CRC in these mutant mice.
PPARβ/δ deﬁciency in ﬁbroblasts lowers oxidative
stress in HCT116, HT29, and iCEC cells
As shown earlier in the inﬂammatory model, FSPCre-
Pparb/d−/− colons had a less-inﬂamed phenotype, with
more anti-inﬂammatory cytokines and less-inﬂammatory
cytokines, compared with their Pparβ/δﬂ/ﬂ littermates.
Inﬂammatory immune cells release a myriad cytokines,
growth factors, and ROS to create an inﬂammatory micro-
environment that is conducive for tumor development [43,
44]. Thus, we questioned if inﬁltrating immune cells could
contribute to the difference in the tumor load between
FSPCre-Pparb/d−/− and Pparb/dﬂ/ﬂ mice. We did not
observe differences in the number of CD11b+ immune cell
numbers between two genotypes (Fig. 4a, b). Although the
total number of inﬁltrating CD11b+ immune cells was
similar, multiplex immunoassay analysis (Supplementary
Table 1) suggested potential differences in the relative
abundance of neutrophils, T-cells and macrophages
between FSPCre-Pparb/d−/− and Pparb/dﬂ/ﬂ colons. We did
not ﬁnd any signiﬁcant difference in the number of inﬁl-
trating neutrophils (Ly6G+CD11b+) and T lymphocytes
(CD3+CD11b+) between the FSPCre-Pparb/d−/− and
Pparb/dﬂ/ﬂ colons as determined by FACS analysis (Sup-
plementary Fig. 2A & B). We noted that the vehicle-treated
FSPCre-Pparb/d−/− colons have a higher inﬁltrated mac-
rophage (F4/80+Cd11b+) than Pparb/dﬂ/ﬂ, which was no
longer distinguishable upon DSS stimulation (Supplemen-
tary Fig. 2C). Further characterization of macrophage sub-
types revealed that vehicle-treated FSPCre-Pparb/d−/−
colons have more of the anti-inﬂammatory M2 macro-
phages, but higher M1 macrophages upon DSS treatment
(Supplementary Fig. 2D). The lower M1:M2 ratio in
FSPCre-Pparb/d−/− colon was consistent with the reduced
inﬂammatory cytokine landscape. Clinical and experimental
evidence have indicated that inﬂammatory milieu and ele-
vated ROS contribute to cancer initiation [45, 46]. ROS
production is usually associated with the activation and
functions of M1 rather than M2 macrophages. Together,
they suggest that immune cells have minor role in tumor
initiation of FSPCre-Pparb/d−/− mice.
Previous study reported that PPARβ/δ in wound ﬁbro-
blasts transcriptionally regulates the expression of H2O2-
detoxifying enzymes, glutathione peroxidase 1 and catalase,
culminating in reduced ROS in the wound microenviron-
ment [8]. Indeed, we detected elevated extracellular H2O2 in
the conditioned medium of PPARβ/δ-deﬁcient ﬁbroblasts
compared to their wild-type counterparts (Fig. 4c). No
signiﬁcant difference in intracellular H2O2 levels in the
ﬁbroblasts (Fig. 4d, e). Explanted FSPCre-Pparb/d−/−
ﬁbroblasts also have overall reduction in the expression
antioxidant genes (8 of 12 genes), suggesting a more oxi-
dative phenotype that contributed to the elevated H2O2
production and secretion into the microenvironment (Fig.
4f). Numerous studies have showed that the activation of
cytoprotective NRF2-mediated stress responsive genes in
response to elevated oxidative stress, like extracellular
H2O2. Thus, to strengthen our observation that the novel
epithelial–mesenchymal communication in oxidative stress
homeostasis was dysregulated in FSPCre-Pparb/d−/−, as
well as a direct effect of ﬁbroblast PPARβ/δ on the oxida-
tive status of adjacent epithelia, we measured ROS in two
different human intestinal cancer cell lines (HCT116 and
HT29) co-cultured with either PPARβ/δ-deﬁcient ﬁbro-
blasts or in conditioned media from FSPCre-Pparb/d−/−
and Pparb/d−/− colonic ﬁbroblasts (Fig. 4g–o). Consistent
with our gene expression data, we detected higher expres-
sion of NRF2 and associated antioxidant enzymes in
HCT116 and HT29 cultured in conditioned media from
FSPCre-Pparb/d−/− than in PPARb/dﬂ/ﬂ colonic ﬁbroblasts
(Fig. 4g, h). This is coupled with reduced ROS levels in
Fig. 2 Loss in ﬁbroblast PPARβ/δ expression retards intestinal
tumorigenesis. a Mean disease activity index (DAI) score of DSS-
treated mice over 7 days. Litter-matched mice were fed with 2% DSS
in drinking water ad libitum and observed at days 3, 5, and 7. DAI
score was computed as detailed in Supplementary Materials and
Methods. Values are mean± S.E.M. (n= 5 for each genotype per
condition). b Representative H&E stained images of mouse colons and
ileums from Pparb/dﬂ/ﬂ and FSPCre-Pparb/d−/− in vehicle- and DSS-
treated conditions. Scale: 100 µm. c Mean villus number measurement
of mouse ilea in Vehicle and DSS-treated mice. H&E stained images
of mouse ilea (n= 8) were used for the recording of villus number in
ImageJ software version 1.45 s. d Length of colons from Pparb/dﬂ/ﬂ
and FSPCre-Pparb/d−/− mice after treatment with vehicle or DSS.
Each data point represents one mouse. e Percentage survival of mice
after AOM/DSS treatment for 10 weeks. Mice were injected with 10
mg/kg AOM. After 1 week, they were given 2% DSS in drinking
water ad libitum. Litter-matched FSPCre-Pparb/d−/− mice (n= 13)
and Pparb/dﬂ/ﬂ mice (n= 18) were used. f Mean DAI score of AOM/
DSS-treated FSPCre-Pparb/d−/− mice (n= 13) and Pparb/dﬂ/ﬂ litter-
mates (n= 18). DAI score was computed as detailed in Supplementary
Materials and Methods. Values are mean± S.E.M. g Representative
images of colons from vehicle- and AOM/DSS-treated Pparb/dﬂ/ﬂ and
FSPCre-Pparb/d−/− mice. Colons were dissected longitudinally from
the distal to proximal end (right to left) and inspected for tumor
number and size using an upright dissecting microscope. Scale: 1 cm.
h Bar graph depicting total colonic tumor numbers per mouse in
AOM/DSS-treated FSPCre-Pparb/d−/− mouse colons (n= 6) and
cognate Pparb/dﬂ/ﬂ colons (n= 6). Values are mean± S.E.M. i Box-
and-whisker plot showing distribution of tumor number and size in
AOM/DSS-treated Pparb/dﬂ/ﬂ and FSPCre-Pparb/d−/− mice. The
tumors were categorized into three groups by tumor diameter (small <
2 mm; middle, 2–4 mm, large> 4 mm). Fewer large tumors were
observed in FSPCre-Pparb/d−/− colons than Pparb/dﬂ/ﬂ colons. Values
are mean± S.E.M. (n= 6 for each genetic background). j Repre-
sentative H&E-stained images of tumors and adjacent colon tissues
from FSPCre-Pparb/d−/− and Pparb/dﬂ/ﬂ mice. Scale: 200 µm
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HCT116 cells cultured in conditioned media from FSPCre-
Pparb/d−/− colonic ﬁbroblasts (Fig. 4i). In support, we also
detected higher NRF2 expression, elevated mRNA levels of
antioxidant enzymes and reduced ROS levels in HCT116
cells when co-cultured with siPPARβ/δ-knockdown BJ-1
ﬁbroblasts (BJ-1siPPARβ/δ) (Fig. 4 j–l) or CCD18Co
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myoﬁbroblasts (CCD18CosiPPARβ/δ) (Fig. 4m–o)compared
with cognate controls (BJ-1siScrambled and CCDCosiScrambled).
We similarly observed an NRF2 antioxidant response in
immortalized non-tumorigenic human colon epithelial cells
cultured in either conditioned media from FSPCre-Pparb/d
−/− or the presence of exogenous H2O2 (Supplementary
Figure 2 E-G). This response was attenuated in the presence
of antioxidant N-acetyl cysteine (NAC). Chronic or repe-
ated exposure to low level of H2O2, in combination with
growth factors, has been shown to exert transformative and
growth-promoting effects on epithelial cells [47]. We
observed an increase in HCT116 cells at either G2/M or S
phase when was co-cultured with PPARβ/δ-knockdown
ﬁbroblast cell lines compared with cognate controls (Sup-
plementary Figure 2H).
Our ﬁndings suggest that an elevated NRF2-related
response in the colon epithelia was associated with reduced
CRC. Thus, we explore the effect of NAC pre-treatment on
CRC initiation in DSS-treated APCmin/+Pparb/dﬂ/ﬂ and
APCmin/+FSPCre-Pparb/d−/− mice (NAC/DSS treatment).
APCmin/+Pparb/dﬂ/ﬂ mice developed more and larger CRCs
than APCmin/+FSPCre-Pparb/d−/− (Supplementary Figure
1L-M). The pre-treatment with NAC reduced the number of
tumors in APCmin/+Pparb/dﬂ/ﬂ by 87% when compared no
NAC pre-treatment (Supplementary Figure 1N-P), sug-
gesting that ROS have an important role in early tumor
development. There was no difference in the number of
tumors between NAC pre-treated or untreated APCmin/
+FSPCre-Pparb/d−/− mice (Supplementary 1L & O), sug-
gesting that further reduction in epithelial ROS has minimal
impact on tumor development. Paradoxically, we observed
a reduced median survival rate of the APCmin/+FSPCre-
Pparb/d−/− mice pre-treated with NAC (Fig. 1n). Although
the precise reason for this observation is unclear, we spec-
ulate that additional reduction in epithelial ROS might have
disrupted critical ROS-mediated cellular functions neces-
sary for homeostasis in APCmin/+FSPCre-Pparb/d−/− mice,
which already have elevated NRF2 antioxidant response.
Studies from the past two decades have established that
ROS serve as signaling molecules to regulate biological and
physiological processes [48]. Clearly, future experiments
will be necessary to understand the effect of antioxidant
treatment on normal cellular functions in FSPCre-Pparb/d
−/− mice, as well as the optimal antioxidant treatment
regime to reduce CRC in wild-type mice.
We showed a major role for stromal PPARβ/δ in ROS
production that consequently conjures an NRF2-mediated
antioxidant response, reducing ROS levels in the adjacent
intestinal epithelial cancer cells. NRF2-mediated response
also results in the activation of various signaling pathways
that facilitates tumor cell senescence [49, 50]. Collectively,
we propose that FSPCre-Pparb/d−/− colonic epithelium are
subjected to a constant dose of ROS, extracellular H2O2
from their neighboring stroma, which triggers NRF2-
mediated signaling that suppresses tumor development.
Conclusion
Our data have shown that PPARβ/δ ablation in ﬁbroblasts
results in reduced tumorigenesis across three different mice
models of CRC. Microarray gene expression and gene
Fig. 3 Fibroblast PPARβ/δ alters NRF2 and associated oxidative
processes in FSPCre-Pparb/d−/− intestinal epithelium. a–c Gene
Ontological Pathway Analysis of differentially expressed genes from
colon mucosa (a), ileum mucosa (b), and intestinal tumor epithelium
(c). Total RNA was isolated from LCM tissues using the Ambion
RecoverAll Total Nucleic Acid Isolation Kit for FFPE and processed
for array hybridization using the GeneChip WT Pico Kit and Gene-
Chip Mouse Gene 1.0 ST Array gene chips. The data were normalized
and analyzed using the Partek Genomics Suite v6.6. Multi-way
ANOVA analysis was used to compare FSPCre-Pparb/d−/− (KO)
against Pparb/dﬂ/ﬂ (WT). Gene ontology (GO) analysis of gene subsets
was performed using the Ingenuity Pathway Analysis software. The
top ﬁve GO analysis were in descending order as determined by their
p-value. Pathway analyses were conducted using Ingenuity Pathway
Analysis (IPA), comparing FSPCre-Pparb/d−/− (KO) against Pparb/
dﬂ/ﬂ (WT) samples (n= 3; Fold change cutoff ≥± 1.3; p< 0.05). *
Oxidative Phosphorylation and Mitochondrial Dysfunction were two
common pathways placed in the top three most signiﬁcant pathways
across all tissues. d, e Unguided hierarchical clustering by upstream
regulator (d) and pathway analysis (e) of differentially expressed genes
in normal, tumor adjacent and tumor epithelium tissues from FSPCre-
Pparb/d−/− (KO) and Pparb/dﬂ/ﬂ (WT) mice. Our analysis also ﬂagged
NRF2-mediated oxidative stress response as an upregulated pathway
in FSPCre-Pparb/d−/− colonic epithelium. *NFE2L2 (Nuclear factor
erythroid 2-related factor 2) is a synonym of NRF2 (Nuclear factor
erythroid 2-related factor 2). f Intracellular H2O2 levels in colons from
FSPCre-Pparb/d−/− and Pparb/dﬂ/ﬂ mice as determined by Amplex
Red H2O2 assay. Samples were homogenized and supernatants incu-
bated with appropriate reagents according to manufacturer’s instruc-
tions. Oxidation of Amplex Red results in the production of
ﬂuorescent resorunﬁn (571 nm ex and 585 nm em). A calibration curve
was prepared (0–20 μM) and used to calculate H2O2 concentration of
samples. The concentration of H2O2 was normalized to total protein.
Data are represented as mean± S.E.M. from at least four independent
experiments. g Relative fold change in mRNA levels of 13 genes
associated with oxidative stress response in APCmin/+FSPCre-Pparb/d
−/− and APCmin/+Pparb/dﬂ/ﬂ colons. Total RNA was extracted, and
RT-qPCR was performed as described in legends of Fig. 1d, e.
Ribosomal RNA L27 used as housekeeping gene. Values are mean±
S.E.M. (n= 4). *p< 0.05. h Representative images of immunohisto-
chemical staining for NRF2 (black arrows) in FSPCre-Pparb/d−/− and
Pparb/dﬂ/ﬂ colons. Sections were counterstained with hematoxylin for
visualization of tissue morphology. The number of NRF2-positive
cells was recorded using ImageJ software version 1.45 s. Black arrows
indicate representative NR2-positive regions. Scale bar: 50 µm. i Fold
change in NRF2 protein in colons from FSPCre-Pparb/d−/− and
Pparb/dﬂ/ﬂ mice. Representative immunoblot and graph for NRF2
protein are shown. Samples were processs for western bllot as
described in legends of Fig. 1d, e. PCNA that served as housekeeping
protein were from the same samples. Data are represented as mean± S.
E.M. from at least three independent experiments
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ontology analyses, together with in vivo and in vitro
experiments indicate that PPARβ/δ depletion in ﬁbroblasts
alters the antioxidant responses and thus the oxidative status
of the adjacent epithelium. We propose that PPARβ/δ
deﬁciency in ﬁbroblasts increases extracellular H2O2, trig-
gering an NRF2-mediated antioxidant response in the
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adjacent epithelia. The elevated expression of NRF2-
dependent proteins is critical for eliminating carcinogens
to maintain cellular redox homeostasis. Consequently,
FSPCre-Pparb/d−/− mice have reduced colonic polyp
formation.
Nuclear receptor PPARβ/δ has been implicated in CRC,
although it remained controversial as studies have shown
supporting evidence for PPARβ/δ playing an anti-
tumorigenic [16] and pro-tumorigenic roles in CRC [51].
It is conceivable that PPARβ/δ has dual roles in tumor-
igenesis, much like TGF-β1 and ROS. By regulating cell
growth, death, and immortalization, TGFβ signaling path-
ways exert tumor suppressor effects in normal cells and
early carcinomas. But as tumors progress, these protective
and cytostatic effects of TGFβ are often lost, switching to
promote cancer progression, invasion, and tumor metas-
tasis. Similarly, chronic oxidative stress has been shown to
promote tumorigenesis [47, 52], whereas the modulation of
oxidative stress as an anticancer therapeutic agent has also
been discussed [53]. With the temporal and dose-dependent
basis of oxidative stress on tumor formation and develop-
ment, this may explain the dual effect of PPARβ/δ on
tumorigenesis.
Limitations of our study include that one genetic back-
ground of mouse and our deletion strategy consists of the
deletion of exons coding for the DNA-binding domain of
PPARβ/δ. Different mouse strains may exhibit different
susceptibility to carcinogen or tolerance to oxidative stress.
It is also conceivable that other gene deletion strategies may
result in different phenotypic severity or outcomes owing to
differences in vulnerabilities to the oxidative stress. FSP1 is
a key marker of a speciﬁc subset of macrophages in the liver
during ﬁbrosis and injury [54], although no report has
described confounding issues in other organs. Nevertheless,
to the best of our knowledge, this is the ﬁrst study to
examine the role of ﬁbroblast PPARβ/δ in CRC, which
reveals novel epithelial–mesenchymal communication in
ROS homeostasis. Our results illustrate that PPARβ/δ
modulation of oxidative stress has potential medical
applicability.
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license as the original. The images or other third party material in this
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indicated otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons license and your intended
Fig. 4 PPARβ/δ deﬁciency in ﬁbroblasts lowers oxidative stress in
colon cell lines. a, b FACS analysis of CD11b+ cell numbers in
colons from FSPCre-Pparb/d−/− and Pparb/dﬂ/ﬂ mice treated with
vehicle or DSS (a) and APCmin/+FSPCre-Pparb/d−/− and APCmin/
+Pparb/dﬂ/ﬂ colons (b). Fresh tissue biopsies were dissociated using
the gentleMACS Dissociator according to manufacturer’s instruction.
Homogenates were strained, washed, and processed for staining with
ﬂuorophore-conjugated antibodies on ice. Flow cytometry was per-
formed using Accuri C6 Flow Cytometer and analyzed on FlowJo
v10.0.7. Values are mean± S.E.M. (n= 6). c Extracellular H2O2 levels
of explanted ﬁbroblasts from Pparb/dﬂ/ﬂ and FSPCre-Pparb/d−/−
colons detected by Amplex Red Assay as described in legend of Fig.
3f. Values are mean± S.E.M. (n= 6). d, e Intracellular H2O2 levels of
explanted ﬁbroblasts from Pparb/dﬂ/ﬂ and FSPCre-Pparb/d−/− colons
detected by CellROX. Cells were ﬁrst positively gated for ﬁbroblast
marker (CD140a or PDGRA) and the CellROX ﬂuroscence readings
were taken from the CD140a+ gated cells. Values are mean± S.E.M.
(n= 4). fRelative fold change in mRNA levels of 13 genes associated
with oxidative stress response in explanted ﬁbroblasts from Pparb/dﬂ/ﬂ
and FSPCre-Pparb/d−/− colons. Total RNA was extracted, and RT-
qPCR was performed as described in legends of Fig. 1d, e. were
Ribosomal 18S rRNA served as a housekeeping gene. Data are
represented as mean± S.E.M. from 4 independent experiments. * p<
0.05, ** p< 0.01. g, h, k, n Relative fold change in mRNA levels of
13 genes associated with oxidative stress response in HCT116 (g, k, n)
and HT29 cells (h) cultured in conditioned medium of ﬁbroblasts from
Pparb/dﬂ/ﬂ and FSPCre-Pparb/d−/− (g, h), or co-cultured with BJ-1 (k)
and CCD18Co cells (n) whose endogenous PPARβ/δ was suppressed
by siRNA. Cells transfected with siRNA of PPARβ/δ and Scrambled
were denoted by superscript. Data are represented as mean± S.E.M.
from four independent experiments. * p< 0.05, ** p< 0.01. i, l, o
Intracellular oxidative stress levels in HCT116 cells (i, l, o) either
cultured in condition medium of ﬁbroblasts from Pparb/dﬂ/ﬂ and
FSPCre-Pparb/d−/− (i) or co-cultured with BJ-1 (l) and CCD18Co
cells (o) whose endogenous PPARβ/δ was suppressed by siRNA. Cells
transfected with Scrambled siRNA served as cognate controls. Intra-
cellular ROS level of HCT116 cells cultured in conditioned medium
from or co-cultured with PPARβ/δ-deﬁcient ﬁbroblasts as determined
by CM-H2DCFDA assay. Values are mean± S.E.M. (n= 4). j, m
Relative fold change in PPARβ/δ mRNA expression in BJ-1 ﬁbro-
blasts (j) and CCD18co myoﬁbroblasts (m) whose endogenous
PPARβ/δ was suppressed by siRNA at 48 and 72 h post transfection.
Cells transfected with Scrambled siRNA served are cognate controls.
18 S rRNA served as housekeeping gene. Data are represented as
mean± S.E.M. from four independent experiments. * P< 0.05, ** P
< 0.01
2076 E. H. P. Tan et al.
use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright
holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by-nc-sa/4.0/.
References
1. Quail DF, Joyce JA. Microenvironmental regulation of tumor
progression and metastasis. Nat Med. 2013;19:1423–37.
2. Udagawa T, Wood M. Tumor-stromal cell interactions and
opportunities for therapeutic intervention. Curr Opin Pharmacol.
2010;10:369–74.
3. Holmstrom KM, Finkel T. Cellular mechanisms and physiological
consequences of redox-dependent signalling. Nat Rev Mol Cell
Biol. 2014;15:411–21.
4. Manda G, Isvoranu G, Comanescu MV, Manea A, Debelec
Butuner B, Korkmaz KS. The redox biology network in cancer
pathophysiology and therapeutics. Redox Biol. 2015;5:347–57.
5. Chaiswing L, Oberley TD. Extracellular/microenvironmental
redox state. Antioxid Redox Signal. 2010;13:449–65.
6. Espinosa-Diez C, Miguel V, Mennerich D, Kietzmann T,
Sanchez-Perez P, Cadenas S, et al. Antioxidant responses and
cellular adjustments to oxidative stress. Redox Biol.
2015;6:183–97.
7. Panieri E, Santoro MM. ROS homeostasis and metabolism: a
dangerous liason in cancer cells. Cell Death Dis. 2016;7:e2253.
8. Wang X, Sng MK, Foo S, Chong HC, Lee WL, Tang MB, et al.
Early controlled release of peroxisome proliferator-activated
receptor beta/delta agonist GW501516 improves diabetic wound
healing through redox modulation of wound microenvironment. J
Control Release. 2015;197:138–47.
9. Peters JM, Gonzalez FJ, Muller R. Establishing the role of
PPARbeta/delta in carcinogenesis. Trends Endocrinol Metab.
2015;26:595–607.
10. Tan NS, Vazquez-Carrera M, Montagner A, Sng MK, Guillou H,
Wahli W. Transcriptional control of physiological and patholo-
gical processes by the nuclear receptor PPARbeta/delta. Prog
Lipid Res. 2016;64:98–122.
11. He TC, Chan TA, Vogelstein B, Kinzler KW. PPARdelta is an
APC-regulated target of nonsteroidal anti-inﬂammatory drugs.
Cell. 1999;99:335–45.
12. Montagner A, Delgado MB, Tallichet-Blanc C, Chan JS, Sng MK,
Mottaz H, et al. Src is activated by the nuclear receptor peroxi-
some proliferator-activated receptor beta/delta in ultraviolet
radiation-induced skin cancer. EMBO Mol Med. 2014;6:80–98.
13. Zhang W, Xu Y, Xu Q, Shi H, Shi J, Hou Y. PPARdelta promotes
tumor progression via activation of Glut1 and SLC1-A5 tran-
scription. Carcinogenesis. 2017;38:748–55.
14. Marin HE, Peraza MA, Billin AN, Willson TM, Ward JM, Ken-
nett MJ, et al. Ligand activation of peroxisome proliferator-
activated receptor beta inhibits colon carcinogenesis. Cancer Res.
2006;66:4394–401.
15. Wang D, Wang H, Guo Y, Ning W, Katkuri S, Wahli W, et al.
Crosstalk between peroxisome proliferator-activated receptor delta
and VEGF stimulates cancer progression. Proc Natl Acad Sci
USA. 2006;103:19069–74.
16. Wang D, Fu L, Ning W, Guo L, Sun X, Dey SK, et al. Peroxisome
proliferator-activated receptor delta promotes colonic inﬂamma-
tion and tumor growth. Proc Natl Acad Sci USA.
2014;111:7084–9.
17. Kilgore KS, Billin AN. PPARbeta/delta ligands as modulators of
the inﬂammatory response. Curr Opin Investig Drugs.
2008;9:463–9.
18. Borland MG, Yao PL, Kehres EM, Lee C, Pritzlaff AM, Ola E,
et al. Editor’s highlight: PPARbeta/delta and PPARgamma inhibit
melanoma tumorigenicity by modulating inﬂammation and
apoptosis. Toxicol Sci. 2017;159:436–48.
19. Zuo X, Peng Z, Moussalli MJ, Morris JS, Broaddus RR, Fischer
SM, et al. Targeted genetic disruption of peroxisome proliferator-
activated receptor-delta and colonic tumorigenesis. J Natl Cancer
Inst. 2009;101:762–7.
20. Zuo X, Xu M, Yu J, Wu Y, Moussalli MJ, Manyam GC, et al.
Potentiation of colon cancer susceptibility in mice by colonic
epithelial PPAR-delta/beta overexpression. J Natl Cancer Inst.
2014;106:dju052.
21. Chan JSK, Sng MK, Teo ZQ, Chong HC, Twang JS, Tan NS.
Targeting nuclear receptors in cancer-associated ﬁbroblasts as
concurrent therapy to inhibit development of chemoresistant
tumors. Oncogene 2017. https://doi.org/10.1038/onc.2017.319
22. Pinchuk IV, Mifﬂin RC, Saada JI, Powell DW Intestinal
mesenchymal cells. Curr Gastroenterol Rep. 2010;12:310–8.
23. Okada H, Inoue T, Kanno Y, Kobayashi T, Watanabe Y, Ban S,
et al. Selective depletion of ﬁbroblasts preserves morphology and
the functional integrity of peritoneum in transgenic mice with
peritoneal ﬁbrosing syndrome. Kidney Int. 2003;64:1722–32.
24. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski
JE, et al. Identiﬁcation and characterization of a ﬁbroblast marker:
FSP1. J Cell Biol. 1995;130:393–405.
25. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N,
Shappell S, et al. TGF-beta signaling in ﬁbroblasts modulates the
oncogenic potential of adjacent epithelia. Science.
2004;303:848–51.
26. Liu X, Pitarresi JR, Cuitino MC, Kladney RD, Woelke SA,
Sizemore GM, et al. Genetic ablation of Smoothened in pancreatic
ﬁbroblasts increases acinar-ductal metaplasia. Genes Dev.
2016;30:1943–55.
27. Pickup MW, Hover LD, Polikowsky ER, Chytil A, Gorska AE,
Novitskiy SV, et al. BMPR2 loss in ﬁbroblasts promotes mam-
mary carcinoma metastasis via increased inﬂammation. Mol
Oncol. 2015;9:179–91.
28. Yu S, Yeh CR, Niu Y, Chang HC, Tsai YC, Moses HL, et al.
Altered prostate epithelial development in mice lacking the
androgen receptor in stromal ﬁbroblasts. Prostate.
2012;72:437–49.
29. Iglesias J, Barg S, Vallois D, Lahiri S, Roger C, Yessoufou A,
et al. PPARbeta/delta affects pancreatic beta cell mass and insulin
secretion in mice. J Clin Invest. 2012;122:4105–17.
30. Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM,
et al. Direct evidence for epithelial-mesenchymal transitions in
breast cancer. Cancer Res. 2008;68:937–45.
31. Roncoroni L, Elli L, Doneda L, Piodi L, Ciulla MM, Paliotti R,
et al. Isolation and culture of ﬁbroblasts from endoscopic duo-
denal biopsies of celiac patients. J Transl Med. 2009;7:40.
32. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in
patients with ulcerative colitis: a meta-analysis of population-
based cohort studies. Clin Gastroenterol Hepatol.
2012;10:639–45.
33. Kim ER, Chang DK. Colorectal cancer in inﬂammatory bowel
disease: the risk, pathogenesis, prevention and diagnosis. World J
Gastroenterol. 2014;20:9872–81.
34. Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the
importance of context. Nat Rev Cancer. 2012;12:564–71.
35. Khor TO, Huang MT, Prawan A, Liu Y, Hao X, Yu S, et al.
Increased susceptibility of Nrf2 knockout mice to colitis-
associated colorectal cancer. Cancer Prev Res (Phila).
2008;1:187–91.
36. Saw CL, Kong AN. Nuclear factor-erythroid 2-related factor 2 as
a chemopreventive target in colorectal cancer. Expert Opin Ther
Targets. 2011;15:281–95.
Role of PPARβ/δ-null ﬁbroblasts in tumor load reduction 2077
37. Reddy RC, Standiford TJNrf2. and PPAR{gamma}: PPARtnering
against oxidant-induced lung injury. Am J Respir Crit Care Med.
2010;182:134–5.
38. Cho HY, Gladwell W, Wang X, Chorley B, Bell D, Reddy SP,
et al. Nrf2-regulated PPAR{gamma} expression is critical to
protection against acute lung injury in mice. Am J Respir Crit
Care Med. 2010;182:170–82.
39. Park EY, Cho IJ, Kim SG. Transactivation of the PPAR-
responsive enhancer module in chemopreventive glutathione S-
transferase gene by the peroxisome proliferator-activated receptor-
gamma and retinoid X receptor heterodimer. Cancer Res.
2004;64:3701–13.
40. Kim HJ, Ham SA, Kim MY, Hwang JS, Lee H, Kang ES, et al.
PPARdelta coordinates angiotensin II-induced senescence in
vascular smooth muscle cells through PTEN-mediated inhibition
of superoxide generation. J Biol Chem. 2011;286:44585–93.
41. Kim MY, Kang ES, Ham SA, Hwang JS, Yoo TS, Lee H, et al.
The PPARdelta-mediated inhibition of angiotensin II-induced
premature senescence in human endothelial cells is SIRT1-
dependent. Biochem Pharmacol. 2012;84:1627–34.
42. Liu J, Wang P, He L, Li Y, Luo J, Cheng L, et al. Cardiomyocyte-
restricted deletion of PPARbeta/delta in PPARalpha-null mice
causes impaired mitochondrial biogenesis and defense, but no
further depression of myocardial fatty acid oxidation. PPAR Res.
2011;2011:372854.
43. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA.
Inﬂammation-induced cancer: crosstalk between tumours,
immune cells and microorganisms. Nat Rev Cancer.
2013;13:759–71.
44. Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune
cells in the tumor microenvironment. Nat Immunol.
2013;14:1014–22.
45. Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic
Res. 2010;44:479–96.
46. Shalapour S, Karin M. Immunity, inﬂammation, and cancer: an
eternal ﬁght between good and evil. J Clin Invest.
2015;125:3347–55.
47. Chan JS, Tan MJ, Sng MK, Teo Z, Phua T, Choo CC, et al.
Cancer-associated ﬁbroblasts enact ﬁeld cancerization by pro-
moting extratumoral oxidative stress. Cell Death Dis. 2017;8:
e2562.
48. Finkel T. Signal transduction by reactive oxygen species. J Cell
Biol. 2011;194:7–15.
49. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell meta-
bolism. Nat Rev Cancer. 2011;11:85–95.
50. Ramsey MR, Sharpless NE. ROS as a tumour suppressor? Nat
Cell Biol. 2006;8:1213–5.
51. Harman FS, Nicol CJ, Marin HE, Ward JM, Gonzalez FJ, Peters
JM. Peroxisome proliferator-activated receptor-delta attenuates
colon carcinogenesis. Nat Med. 2004;10:481–3.
52. Khansari N, Shakiba Y, Mahmoudi M. Chronic inﬂammation and
oxidative stress as a major cause of age-related diseases and
cancer. Recent Pat Inﬂamm Allergy Drug Discov. 2009;3:73–80.
53. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as
an anticancer strategy. Nat Rev Drug Discov. 2013;12:931–47.
54. Osterreicher CH, Penz-Osterreicher M, Grivennikov SI, Guma M,
Koltsova EK, Datz C, et al. Fibroblast-speciﬁc protein 1 identiﬁes
an inﬂammatory subpopulation of macrophages in the liver. Proc
Natl Acad Sci USA. 2011;108:308–13.
2078 E. H. P. Tan et al.
